As of 2025-07-01, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (8.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -184.3%.
The range of the Relative Valuation is (6.17) - (11.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 17.7x | 12.6x |
| Forward P/E multiples | 9.9x - 20.1x | 13.1x |
| Fair Price | (6.17) - (11.02) | (8.01) |
| Upside | -165.0% - -216.0% | -184.3% |
| Date | P/E |